Bone resorption inhibitor alendronate enhances anabolic action of the lip isoform of C/EBP beta

被引：0
|
作者：
Smink, J. [1 ,2 ]
Mehta, M. [2 ,3 ]
Rijckaert, B. [1 ,2 ]
Duda, G. [2 ,3 ]
Leutz, A. [1 ,2 ]
机构：
[1] Max Delbrueck Ctr Mol Med, Berlin, Germany
[2] Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany
[3] Julius Wolff Inst, Ctr Musculoskeletal Surg, Berlin, Germany
来源：
BONE | 2011年 / 48卷
关键词：
D O I：
10.1016/j.bone.2011.03.192
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S112 / S112
页数：1
相关论文
共 50 条
  • [21] An Isoform of C/EBPβ, LIP, Regulates Expression of the Chemokine Receptor CXCR4 and Modulates Breast Cancer Cell Migration
    Park, Bae-Hang
    Kook, Sungho
    Lee, SeanBong
    Jeong, Jong-Hyeon
    Brufsky, Adam
    Lee, Byeong-Chel
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (40) : 28656 - 28667
  • [22] Combined Irradiation by Gamma Rays and Carbon Nuclei Increases the C/EBP-β LIP Isoform Content in the Pituitary Gland of Rats
    Anokhina I.P.
    Anokhin P.K.
    Kokhan V.S.
    Doklady Biological Sciences, 2019, 488 (1) : 133 - 135
  • [23] LIP, a natural truncated isoform of the transcription factor C/EBPβ, promotes osteoblastogenesis and inhibits adipogenesis in the mesenchymal stem cells.
    Hata, K
    Ikeda, F
    Yamashita, K
    Ichida, F
    Matsubara, T
    Nokubi, T
    Yamaguchi, A
    Nishimura, R
    Yoneda, T
    JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S151 - S151
  • [24] Regulation of C/EBP beta isoform synthesis in LPS-treated mouse livers by alternative translational initiation
    Xiong, W
    Xie, Q
    Hsieh, CC
    Papaconstantinou, J
    MOLECULAR BIOLOGY OF THE CELL, 1997, 8 : 2524 - 2524
  • [25] Dabigatran etexilate, a new direct thrombin inhibitor, enhances bone mass, inhibits bone resorption and stimulates bone formation in mice.
    Kalinowski, Judy
    Jastrzebski, Sandra
    Won, Hee Yeun
    Mirza, Faryal
    Lee, Sun-Kyeong
    Lorenzo, Joseph
    JOURNAL OF BONE AND MINERAL RESEARCH, 2014, 29 : S260 - S260
  • [26] Cx43 Scaffolding Cytoplasmic Domain Restrains Bone Resorption but is Dispensable for the Anabolic Action of Intermittent PTH Administration
    Da Costa, Rafael Pacheco
    Hassan, Iraj
    Tu, Xiaolin
    Reginato, Rejane D.
    Katchburian, Eduardo
    Bellido, Teresita
    Plotkin, Lilian
    JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28
  • [27] Impaired generation of bone marrow B lymphocytes in mice deficient in C/EBP beta
    Chen, XN
    Liu, WM
    Ambrosino, C
    Ruocco, MR
    Poli, V
    Romani, L
    Quinto, I
    Barbieri, S
    Holmes, KL
    Venuta, S
    Scala, G
    BLOOD, 1997, 90 (01) : 156 - 164
  • [28] Blockade of Osteoclast-Mediated Bone Resorption with a RANKL Inhibitor Enhances Spinal Fusion in a Rat Model
    Payne, Karin
    Erickson, Christopher
    Shaw, Nichole
    Yarger, Peter
    Baldini, Todd
    Kleck, Christopher
    Patel, Vikas
    Burger, Evalina
    JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 : S348 - S349
  • [29] The shortest isoform of C/EBPβ, liver inhibitory protein (LIP), collaborates with Evi1 to induce AML in a mouse BMT model
    Watanabe-Okochi, Naoko
    Yoshimi, Akihide
    Sato, Tomohiko
    Ikeda, Toshiyuki
    Kumano, Keiki
    Taoka, Kazuki
    Satoh, Yumiko
    Shinohara, Akihito
    Tsuruta, Takako
    Masuda, Akiko
    Yokota, Hiromitsu
    Yatomi, Yutaka
    Takahashi, Koki
    Kitaura, Jiro
    Kitamura, Toshio
    Kurokawa, Mineo
    BLOOD, 2013, 121 (20) : 4142 - 4155
  • [30] Alendronate mechanism of action:: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro
    Fisher, JE
    Rogers, MJ
    Halasy, JM
    Luckman, SP
    Hughes, DE
    Masarachia, PJ
    Wesolowski, G
    Russell, RGG
    Rodan, GA
    Reszka, AA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (01) : 133 - 138
12345